The Patent Finder

Semafore Pharmaceuticals, Inc.

Also on record
Records under this name other than patents Semafore Pharmaceuticals, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.

Showing 1 to 3 of 3 · Back to Semafore Pharmaceuticals, Inc.

Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleStatus Expires Confidence
US 7,662,977PI-3 kinase inhibitor prodrugs
Formerly held
Lapsed on the fee record
Ended Feb 16, 2022 · USPTO record
Lapsed on the fee recordEnded Feb 16, 2022USPTO record
US 7,396,828PI-3 kinase inhibitor prodrugs
Formerly held
Lapsed on the fee record
Ended Jul 8, 2016 · USPTO record
Lapsed on the fee recordEnded Jul 8, 2016USPTO record
US 6,949,537PI-3 kinase inhibitor prodrugs
Formerly held
Lapsed on the fee record
Ended Sep 27, 2013 · USPTO record
Lapsed on the fee recordEnded Sep 27, 2013USPTO record
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 22, 2026 · includes USPTO assignment data published Nov 21, 2026, status data published Nov 22, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited